Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Aurinia Pharmaceuticals Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Aurinia Pharmaceuticals held its annual shareholder meeting on June 3, 2026, electing five board members with strong shareholder support ranging from 86.50% to 96.59%, signaling stable governance and investor confidence in the company's leadership direction.
Key Takeaways
Five board members elected: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson, and Tina S. Nova, serving until the 2027 annual meeting
Kevin Tang received the highest shareholder support at 96.59% of votes in favor
2 more takeaways